Camena Bioscience, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...